Sodium-iodide symporter positive cells after intracellular uptake of 99mTc versus α-emitter 211At: Reduction of clonogenic survival and characterization of DNA damage;Natrium-Iodid-Symporter-positive Zellen nach intrazellulärer Aufnahme von 99mTc im Vergleich zum α-Emitter 211At - Reduktion des klonogenen Überlebens und Charakterisierung von DNA-Schäden

NuklearMedizin

Volumn 51, Issue 5, 2012, Pages 170-178

  Kotzerke, Jörg ^a   Wendisch, M ^a   Freudenberg, R ^a   Runge, R ^a   Oehme, L ^a   Meyer, G J ^b   Kunz Schughart, L A ^a   Wunderlich, G ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

211At; 99mTc; Auger emitters; Clonogenic cell survival; Comet assay; Radiobiology; Radionuclides; Sodium iodide symporter

Indexed keywords

ASTATINE 211; PERCHLORATE; PERTECHNETIC ACID TC 99M; SODIUM IODIDE; TECHNETIUM 99M;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL SURVIVAL; COMET ASSAY; CONTROLLED STUDY; DNA DAMAGE; DOSE CALCULATION; DRUG UPTAKE; ELECTRON; NONHUMAN; PATIENT MONITORING; RADIOACTIVITY; RAT; THYROID CELL;

ANIMALS; ASTATINE; CELL LINE; CELL SURVIVAL; COLONY-FORMING UNITS ASSAY; DNA DAMAGE; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTRONS; RADIATION DOSAGE; RATS; SYMPORTERS; TECHNETIUM; THYROID GLAND;

EID: 84867288911     PISSN: 00295566     EISSN: None     Source Type: Journal    
DOI: 10.3413/Nukmed-0506-12-05     Document Type: Article

References (52)

1. Agostinelli S, Allison J, Amako K et al. GEANT4-a simulation toolkit. Nuclear Instruments & Methods in Physics Research Section a-Accelerators Spectrometers Detectors and Associated Equipment 2003; 506: 250-303.
2. Allison J, Amako K, Apostolakis J et al. Geant4 developments and applications. IEEE Transactions on Nuclear Science 2006; 53: 270-278.
3. Balagurumoorthy P, Chen K, Adelstein SJ et al. Auger electron-induced double-strand breaks depend on DNA topology. Radiat Res 2008; 170: 70-82.
4. Bloomer WD, Adelstein SJ. 5-125I-iododeoxyuridine as prototype for radionuclide therapy with Auger emitters. Nature 1977; 265: 620-621.
5. Calini V, Urani C, Camatini M. Comet assay evaluation of DNA single-and double-strand breaks induction and repair in C3H10T1/2 cells. Cell Biol Toxicol 2002; 18: 369-379.
6. Carlin S, Akabani G, Zalutsky MR. In vitro cyto-toxicity of 211At-astatide and 131I-iodide to glioma tumor cells expressing the sodium/iodide symporter. J Nucl Med 2003; 44: 1827-1838.
7. Carlin S, Mairs RJ, Welsh P et al. Sodium-iodide symporter (NIS)-mediated accumulation of [211At]astatide in NIS-transfected human cancer cells. Nucl Med Biol 2002; 29: 729-739.
8. Chan PC, Lisco E, Lisco H et al. The radiotoxicity of iodine-125 in mammalian cells II. A comparative study on cell survival and cytogenetic responses to 125IUdR, 131TUdR, and 3HTdR. Radiat Res 1976; 67: 332-343.
9. Claesson AK, Stenerlow B, Jacobsson L et al. Relative biological effectiveness of the alpha-particle emitter 211At for double-strand break induction in human fibroblasts. Radiat Res 2007; 167: 312-318.
10. Elgqvist J, Bernhardt P, Hultborn R et al. Myelotoxicity and RBE of 211At-conjugated monoclonal antibodies compared with 99mTc-conjugated monoclonal antibodies and 60Co irradiation in nude mice. J Nucl Med 2005; 46: 464-471.
11. Feinendegen LE. Biological damage from the Auger effect, possible benefits. Radiat Environ Biophys 1975; 12: 85-99.
12. Freudenberg R, Andreeff M, Oehme L et al. Dosimetry of cell-monolayers in multiwell plates. Nuklear medizin 2009; 48: 120-126.
13. Freudenberg R, Wendisch M, Kotzerke J. Geant4-Simulations for cellular dosimetry in nuclear medicine. Z Med Phys 2011; 21: 281-289.
14. Goddu SM, Howell RW, Bouchet LG et al. MIRD Cellular S Values. Reston: Society of Nuclear Medicine 1997.
15. Haberkorn U, Altmann A, Jiang S et al. Iodide uptake in human anaplastic thyroid carcinoma cells after transfer of the human thyroid peroxidase gene. Eur J Nucl Med 2001; 28: 633-638.
16. Haberkorn U, Kinscherf R, Kissel M et al. Enhanced iodide transport after transfer of the human sodium iodide symporter gene is associated with lack of retention and low absorbed dose. Gene Ther 2003; 10: 774-780.
17. Haefliger P, Agorastos N, Renard A et al. Cell uptake and radiotoxicity studies of an nuclear localization signal peptide-intercalator conjugate labeled with [99mTc(CO)3]+. Bioconjug Chem 2005; 16: 582-587.
18. Haefliger P, Agorastos N, Spingler B et al. Induction of DNA-double-strand breaks by auger electrons from 99mTc complexes with DNA-binding ligands. Chembiochem 2005; 6: 414-421.
19. Helmekea HJ, Mahnke E, Schaardt U et al. External targets for the production of 211At-review and status of the target development at the Hannover cyclotron. Z Med Phys 2004; 14: 195-199.
20. Howell RW. Radiation spectra for Auger-electron emitting radionuclides: report No. 2 of AAPM Nuclear Medicine Task Group No. 6. Med Phys 1992; 19: 1371-1383.
21. Howell RW. Auger processes in the 21st century. Int J Radiat Biol 2008; 84: 959-975.
22. Humm JL, Howell RW, Rao DV. Dosimetry of Auger-electron-emitting radionuclides: report no. 3 of AAPM Nuclear Medicine Task Group No. 6. Med Phys 1994; 21: 1901-1915.
23. Kassis AI. Therapeutic radionuclides: biophysical and radiobiologic principles. Semin Nucl Med 2008; 38: 358-366.
24. Kassis AI, Adelstein SJ. A rapid and reproducible method for the separation of cells from radioactive media. J Nucl Med 1980; 21: 88-90.
25. Kassis AI, Harris CR, Adelstein SJ et al. The in vitro radiobiology of astatine-211 decay. Radiat Res 1986; 105: 27-36.
26. Kobe C, Weber I, Eschner W et al. Graves' disease and radioiodine therapy. Is success of ablation dependent on the choice of thyreostatic medication? Nuklearmedizin 2008; 47: 153-156.
27. Leoni SG, Galante PA, Ricarte-Filho JC et al. Differential gene expression analysis of iodide-treated rat thyroid follicular cell line PCCl3. Genomics 2008; 91: 356-366.
28. Lewis DM. 99Mo supply-the times they are changing. Eur J Nucl Med Mol Imaging 2009; 36: 1371-1374.
29. Lindencrona U, Forssell-Aronsson E, Nilsson M. Transport of free 211At and 125I-in thyroid epithelial cells: effects of anion channel blocker 4,4'-di-isothiocyanostilbene-2,2'-disulfonic acid on apical efflux and cellular retention. Nucl Med Biol 2007; 34: 523-530.
30. Meignan M, Charpentier B, Wirquin E et al. Biological effects and irradiation dose induced in human lymphocytes in vitro by an intracellular radionuclide: 99mTc. Radiat Res 1983; 94: 263-279.
31. Meller B, Deisting W, Wenzel BE et al. Increased radioiodine uptake of thyroid cell cultures after external irradiation. Strahlenther Onkol 2006; 182: 30-36.
32. Muller WU, Ciborovius J, Bauch T et al. Analysis of the action of the restriction endonuclease aluI using three different comet assay protocols. Strahlenther Onkol 2004; 180: 655-664.
33. Neti PV, Howell RW. Log normal distribution of cellular uptake of radioactivity: implications for biologic responses to radiopharmaceuticals. J Nucl Med 2006; 47: 1049-1058.
34. Olive PL. The comet assay. An overview of techniques. Methods Mol Biol 2002; 203: 179-194.
35. Pedraza-Lopez M, Ferro-Flores G, Mendiola-Cruz MT et al. Assessment of radiation-induced DNA damage caused by the incorporation of 99mTcradiopharmaceuticals in murine lymphocytes using single cell gel electrophoresis. Mutat Res 2000; 465: 139-144.
36. Petrich T, Helmeke HJ, Meyer GJ et al. Establishment of radioactive astatine and iodine uptake in cancer cell lines expressing the human sodium/iodide symporter. Eur J Nucl Med Mol Imaging 2002; 29: 842-854.
37. Pomplun E, Sutmann G. Is coulomb explosion a damaging mechanism for 125IUdR? Int J Radiat Biol 2004; 80: 855-860.
38. Pouget JP, Santoro L, Raymond L et al. Cell membrane is a more sensitive target than cytoplasm to dense ionization produced by auger electrons. Radiat Res 2008; 170: 192-200.
39. Runge R, Wendisch M, Wunderlich G et al. DNA damage in lymphocytes after irradiation with 211At and 188Re. Nuklearmedizin 2009; 48: 221-226.
40. Schipper ML, Riese CG, Seitz S et al. Efficacy of 99mTc pertechnetate and 131I radioisotope therapy in sodium/iodide symporter (NIS)-expressing neuroendocrine tumors in vivo. Eur J Nucl Med Mol Imaging 2007; 34: 638-650.
41. Siegel JA, Stabin MG. Absorbed fractions for electrons and beta particles in spheres of various sizes. J Nucl Med 1994; 35: 152-156.
42. Silva CR, Valsa JO, Caldeira-de-araujo A et al. Evaluation of the cytotoxic and mutagenic potentiality of technetium-99m in Escherichi coli. Cell Mol Biol (Noisy-le-grand) 2002; 48: 783-787.
43. Singh NP, Stephens RE, Schneider EL. Modifications of alkaline microgel electrophoresis for sensitive detection of DNA damage. Int J Radiat Biol 1994; 66: 23-28.
44. Smit BS, Slabbert JP, Reinecke SA et al. Comparison of cell inactivation by Auger electrons using the two reagents 4-[123I]iodoantipyrine and [123I]NaI. Radiat Environ Biophys 2001; 40: 47-52.
45. Speit G, Hartmann A. The comet assay: a sensitive genotoxicity test for the detection of DNA damage. Methods Mol Biol 2005; 291: 85-95.
46. Stabin MG, Brill AB. State of the art in nuclear medicine dose assessment. Semin Nucl Med 2008; 38: 308-320.
47. Stinchcomb TG, Roeske JC. Values of "S, " , and <(z1)2> for dosimetry using alpha-particle emitters. Med Phys 1999; 26: 1960-1971.
48. Terrissol M, Peudon A, Kummerle E et al. On the biological efficiency of I-123 and I-125 decay on the molecular level. Int J Radiat Biol 2008; 84: 1063-1068.
49. Van Sande J, Massart C, Beauwens R et al. Anion selectivity by the sodium iodide symporter. Endo-crinology 2003; 144: 247-252.
50. Vitor RF, Esteves T, Marques F et al. 99mTc-tricarbonyl complexes functionalized with anthracenyl fragments: synthesis, characterization, and evaluation of their radiotoxic effects in murine melanoma cells. Cancer Biother Radiopharm 2009; 24: 551-563.
51. Wendisch M, Drechsel J, Freudenberg R et al. Cellular damage in vitro. Nuklearmedizin 2009; 48: 208-214.
52. Wendisch M, Freudenberg R, Drechsel J et al. 99mTc reduces clonogenic survival after intracellular uptake in NIS-positive cells in vitro more than 131I. Nuklearmedizin 2010; 49: 154-160.